14920-81-1Relevant articles and documents
Mori et al.
, p. 77,82 (1962)
Methyl group transfer upon gas phase decomposition of protonated methyl benzoate and similar compounds
Frański, Rafa?,Gierczyk, B?a?ej,Zalas, Maciej,Jankowski, Wojciech,Hoffmann, Marcin
, p. 379 - 384 (2018)
Gas phase decompositions of protonated methyl benzoate and its conjugates have been studied by using electrospray ionization-collision induced dissociation-tandem mass spectrometry. Loss of CO2 molecule, thus transfer of methyl group, has been observed. In order to better understand this process, the theoretical calculations have been performed. For methyl benzoate conjugates, it has been found that position of substituent affects the loss of CO2 molecule, not the electron donor/withdrawing properties of the substituent. Therefore, electrospray ionization-mass spectrometry in positive ion mode may be useful for differentiation of isomers of methyl benzoate conjugates.
Milled Dry Ice as a C1 Source for the Carboxylation of Aryl Halides
O'Brien, Connor J.,Nicewicz, David A.
supporting information, p. 814 - 816 (2021/03/01)
The use of carbon dioxide as a C1 chemical feedstock remains an active field of research. Here we showcase the use of milled dry ice as a method to promote the availability of CO 2in a reaction solution, permitting practical synthesis of arylcarboxylic acids. Notably, the use of milled dry ice produces marked increases in yields relative to those obtained with gaseous CO 2, as previously reported in the literature.
Robust synthesis of NIR-emissive P-rhodamine fluorophores
Arndt, Hans-Dieter,Nasufovic, Veselin,Sauer, Maria,Vilotijevic, Ivan
supporting information, p. 1567 - 1571 (2020/03/06)
P-Rhodamines were accessed by implementing a robust three step sequence consisting of (i) addition of m-metallated anilines to dichlorophosphine oxides, (ii) selective dibromination, and (iii) cyclization of the diaryllithium reagents derived from the dib
APELIN RECEPTOR AGONISTS AND METHODS OF USE THEREOF
-
Paragraph 0478-0479, (2019/02/25)
Provided herein are agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions.